Q3 2024 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2024-11-14 · accession 0001389932-24-000020
$423.3M
Reported value
84
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $39.7M | 9.37% | 401,505 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $27.9M | 6.59% | 13,680,554 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $23.5M | 5.55% | 517,994 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $21.0M | 4.97% | 398,100 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $20.6M | 4.87% | 412,573 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $18.0M | 4.25% | 641,673 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $14.9M | 3.53% | 471,410 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $14.9M | 3.53% | 102,500 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $13.4M | 3.16% | 89,572 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $13.1M | 3.10% | 935,894 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $11.3M | 2.66% | 121,763 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $10.8M | 2.55% | 273,739 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $10.5M | 2.47% | 750,363 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $10.1M | 2.40% | 526,702 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $9.4M | 2.21% | 187,130 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $8.7M | 2.05% | 204,208 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $8.4M | 1.98% | 723,678 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $8.0M | 1.89% | 69,615 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $8.0M | 1.89% | 408,368 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $8.0M | 1.88% | 125,616 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $6.1M | 1.44% | 227,906 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $5.8M | 1.38% | 458,915 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $5.1M | 1.20% | 667,000 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $4.7M | 1.11% | 4,000,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $4.4M | 1.04% | 65,552 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $4.3M | 1.01% | 73,754 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $4.3M | 1.00% | 912,928 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $3.9M | 0.93% | 256,717 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $3.7M | 0.89% | 130,175 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $3.7M | 0.87% | 15,900 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $3.4M | 0.80% | 120,700 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $3.2M | 0.76% | 494,274 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $3.1M | 0.73% | 230,322 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $3.0M | 0.70% | 630,029 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $3.0M | 0.70% | 602,894 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $2.9M | 0.69% | 1,050,118 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $2.9M | 0.69% | 589,561 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $2.9M | 0.69% | 1,704,232 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $2.8M | 0.66% | 254,165 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $2.8M | 0.65% | 122,200 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $2.5M | 0.60% | 207,427 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $2.3M | 0.55% | 251,346 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $2.3M | 0.54% | 250,583 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $2.2M | 0.52% | 1,222,358 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $2.2M | 0.51% | 148,294 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $2.0M | 0.48% | 208,790 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $1.9M | 0.45% | 120,351 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.8M | 0.42% | 146,500 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.8M | 0.42% | 486,667 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $1.7M | 0.39% | 145,000 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.6M | 0.39% | 161,584 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $1.6M | 0.39% | 905,582 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.5M | 0.36% | 243,210 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.5M | 0.35% | 34,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $1.5M | 0.35% | 51,996 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $1.4M | 0.33% | 895,200 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.4M | 0.33% | 1,419,262 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $1.2M | 0.29% | 1,350,708 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $1.2M | 0.28% | 64,479 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $1.1M | 0.27% | 329,579 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $1.1M | 0.25% | 308,497 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $1.0M | 0.24% | 108,108 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $1.0M | 0.24% | 8,500 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $864,000 | 0.20% | 600,000 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $809,436 | 0.19% | 447,202 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $786,898 | 0.19% | 112,414 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $781,204 | 0.18% | 108,200 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $671,488 | 0.16% | 48,800 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $642,855 | 0.15% | 204,081 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $543,750 | 0.13% | 125,000 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $491,318 | 0.12% | 19,110 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $409,159 | 0.10% | 401,136 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $399,990 | 0.09% | 3,000 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $381,823 | 0.09% | 127,700 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $377,229 | 0.09% | 137,174 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $350,652 | 0.08% | 37,664 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $326,239 | 0.08% | 7,775 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $324,147 | 0.08% | 341,064 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $306,432 | 0.07% | 26,786 | Common | SOLE |
| 64131A105 | STIM | NEURONETICS INC | $238,362 | 0.06% | 313,717 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $215,063 | 0.05% | 116,882 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $212,420 | 0.05% | 38,000 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $167,500 | 0.04% | 125,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $159,923 | 0.04% | 192,678 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.